FDA Inspection
Amphastar Pharmaceuticals, Inc.Amphastar Pharmaceuticals, Inc. – FDA Inspection, Apr 3, 2025
Record Details
This FDA Inspection record concerns Amphastar Pharmaceuticals, Inc., with an inspection on April 3, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f3a88961-407c-4d84-af4c-f19faea69e77
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1266798
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Amphastar Pharmaceuticals, Inc.
14| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2025 | Not classified | Los Angeles District Office | |
| March 1, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 22, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 22, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 21, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Amphastar Pharmaceuticals, Inc.
- FDA Inspection 1290538 - 2025-11-07
- FDA Inspection 1229403 - 2024-03-01
- FDA Inspection 1144508 - 2021-06-22
- FDA Inspection 1113865 - 2019-11-22
- FDA Inspection 1115634 - 2019-11-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.